DarioHealth Corp. announced amendments to its bylaws, effective September 18, 2025, involving changes to the designations of its Series A-1, C, C-2, D, D-1, D-2, and D-3 Preferred Stock. The amendments facilitate the mandatory conversion of these preferred shares into common stock or pre-funded warrants, based on the holder's choice. Additionally, holders will receive any accrued and unpaid dividends alongside their conversion shares, subject to certain conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-091718), on September 19, 2025, and is solely responsible for the information contained therein.